Agile Therapeutics Inc (AGRX)
0.38
+0.01
(+2.70%)
USD |
OTCM |
Apr 19, 15:48
Agile Therapeutics Cash from Financing (Quarterly): -0.487M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.487M |
| September 30, 2023 | -0.278M |
| June 30, 2023 | 6.875M |
| March 31, 2023 | 0.778M |
| December 31, 2022 | 0.66M |
| September 30, 2022 | 9.821M |
| June 30, 2022 | 12.22M |
| March 31, 2022 | -0.523M |
| December 31, 2021 | 21.08M |
| September 30, 2021 | 2.262M |
| June 30, 2021 | 6.595M |
| March 31, 2021 | 0.484M |
| December 31, 2020 | 0.325M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.166M |
| March 31, 2020 | 67.49M |
| December 31, 2019 | 19.45M |
| September 30, 2019 | 12.89M |
| June 30, 2019 | 1.404M |
| March 31, 2019 | 8.67M |
| December 31, 2018 | -5.939M |
| September 30, 2018 | -1.686M |
| Date | Value |
|---|---|
| June 30, 2018 | -1.647M |
| March 31, 2018 | -1.616M |
| December 31, 2017 | -1.502M |
| September 30, 2017 | 17.02M |
| June 30, 2017 | -1.45M |
| March 31, 2017 | -0.993M |
| December 31, 2016 | 0.006M |
| September 30, 2016 | -0.166M |
| June 30, 2016 | 0.006M |
| March 31, 2016 | 37.84M |
| December 31, 2015 | 0.061M |
| September 30, 2015 | 0.227M |
| June 30, 2015 | 0.175M |
| March 31, 2015 | 19.52M |
| December 31, 2014 | 0.0674M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 52.63M |
| March 31, 2014 | -0.0402M |
| December 31, 2013 | 0.07M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.523M
Minimum
Mar 2022
67.49M
Maximum
Mar 2020
8.485M
Average
1.404M
Median
Jun 2019
Cash from Financing (Quarterly) Benchmarks
| Altimmune Inc | 72.75M |
| iBio Inc | 4.005M |
| Ampio Pharmaceuticals Inc | 0.00 |
| Oragenics Inc | -0.1806M |
| Actinium Pharmaceuticals Inc | 1.192M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.172M |
| Free Cash Flow | -9.577M |
| Free Cash Flow Per Share (Quarterly) | 0.0579 |
| Free Cash Flow to Equity (Quarterly) | 0.434M |
| Free Cash Flow to Firm (Quarterly) | 0.46M |
| Free Cash Flow Yield | -1.17K% |